Fresenius Medical Care is a global leader in providing products and services for individuals with renal diseases. With a founding year of 1912, the company is committed to improving the lives of chronically and critically ill patients worldwide. With extensive experience in dialysis, innovative research, and a value-based care approach, they strive to enhance the quality of life for patients. The company's portfolio includes a wide range of high-quality healthcare products and services, as well as tailored dialysis treatment options for both in-center and home dialysis. Notably, their last investment, a Post-IPO Equity investment, was made on 25 February 2020. This investment signifies the company's ongoing commitment to furthering its mission and expanding its influence in the Biotechnology, Health Care, and Medical Devices industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | Unknown | - | 25 Feb 2020 | |
| Post-IPO Equity | Unknown | - | 24 Apr 2018 | |
| Post-IPO Equity | Unknown | - | 23 Mar 2016 | |
| Post-IPO Equity | Unknown | - | 26 Jan 2015 | |
| Post-IPO Equity | Unknown | - | 01 Nov 2013 |
No recent news or press coverage available for Fresenius Medical Care.
We care about your data, and we'd love to use cookies make your experience better.
